Brellium, a New York-based AI-powered clinical compliance platform for healthcare, has raised $16.7 million in Series A funding.
Investors
The round came from First Round Capital, Left Lane Capital, Menlo Ventures, Digital Health Venture Partners, Kearny Jackson, and Necessary Ventures, alongside a group of angel investors including Andrew Adams (CEO of Headway), Steve Gutentag, Demitri Karagas (co-founders of Thirty Madison), Cory Levy (Z Fellows), and Fiat Ventures.
Brellium Use of Funds
The company will use the funding to grow its team, accelerate product development, and take meaningful steps toward revolutionizing clinical compliance.
About Brellium
Founded in 2021 by Zach Rosen, Henry Kasa, and Alex Le-Tu, Brellium is a healthcare technology company that offers an AI-powered platform that automates clinical and payer compliance processes. It reviews medical charts, audits documentation, and billing, and integrates with EHR systems for real-time insights. Brellium detects issues like copy-pasted notes, billing errors, and contraindicated prescriptions, improving care quality and helping providers prevent insurance clawbacks. Its clients include notable healthcare organizations such as Grow Therapy, Rula, Headspace, Hopebridge, Lightfully Behavioral Health, and Talkiatry.
Funding Details
Company: Brellium, Inc.
Raised: $16.7M
Round: Series A
Funding Date: April 2025
Lead Investor: First Round Capital
Additional Investors: Left Lane Capital, Menlo Ventures, Digital Health Venture Partners, Kearny Jackson, Necessary Ventures, Andrew Adams, Steve Gutentag, Demitri Karagas, Cory Levy, Fiat Ventures
Company Website: https://www.brellium.com/
Software Category: Healthcare Compliance / AI Healthcare
Source: https://brellium.com/resources/blog/brellium-raises-17-million-to-build-healthcares-ai-powered-clinical-payor-compliance-platform